Non-GMO Dosage and use: Take one (1) capsule once or twice per day on an empty stomach, or as directed by a healthcare practitioner
Please bring any recent relevant blood work with you and inform us of all current supplements, prescriptions and any allergies that you might have at the detailed assessment stage
Here's a realistic clinical picture: semaglutide and tirzepatide have substantial clinical evidence as prescription weight-management tools for eligible patients when prescribed and monitored by qualified healthcare professionals

In STEP 1, 1,961 nondiabetic adults with overweight or obesity achieved an average 14.9% weight loss over 68 weeks when semaglutide was combined with lifestyle changes.20 STEP 2 examined 1210 individuals with T2DM and showed a more modest average weight loss of 9.6%, possibly due to insulin resistance and the influence of other diabetes medications.21 STEP 3 introduced a more intensive lifestyle intervention to participants who were overweight or obese but without T2DMincluding a calorie-restricted diet and behavioral supportand resulted in slightly higher weight loss amongst the 611 study participants, averaging around 16%.22 The STEP 4 trial included 811 individuals who were overweight or obese without diabetes and assessed the impact of discontinuing semaglutide after 20 weeks
Case series: We present a long-term follow-up of treatment with GLP-1 receptor agonist (GLP-1 RA) semaglutide in three patients with PWS without diabetes, one of whom had previously undergone metabolic surgery
Vitamin E [5] Vitamin B2 [6] -Glutathione level is significantly related to Vitamin E level, and supplementation with Vitamin E (100 IU/day) significantly increases Glutathione and lowers lipid per-oxidation and HbA1c concentrations in the erythrocytes of type 1 diabetic patients